“A world where a mother has to choose between medications for her health or education for her child is an unjust world.” This quotation from Gregory’s LinkedIn page explains the mission of mPharma, an innovative technology-driven health inventory and retail pharmacy firm with offices in Ghana, Kenya, Nigeria, Ethiopia, Zambia, Gabon, Rwanda, Malawi, and Uganda.
The organization is establishing a network of pharmacies across Africa in order to deliver more convenient and high-quality healthcare to the continent’s millions of inhabitants.
Gregory Rockson is the co-founder and CEO of mPharma, which has over 850 pharmacy locations in Ghana, Kenya, Nigeria, Ethiopia, Zambia, Gabon, Rwanda, Malawi, and Uganda. The company is trying to enhance patient access to and cost of high-quality medications throughout Africa. It works with 155 hospitals, 850 pharmacies and drug stores, and serves over 2 million people. Its involvement in the healthcare industry has enabled over 400,000 patients to obtain high-quality medicine at a lower cost.
Gregory Rockson, Daniel Shoukimas, and James Finucorie started mPharma in Ghana in 2013 as a pharmacy delivering high-quality medical and pharmaceutical products. Within a few years, the healthcare company has expanded to nine African nations, with its headquarters in Ghana, and is developing a scalable medicine inventory management system based on the Airbnb model to enable vendor-managed inventory for African healthcare providers.
Gregory and his co-founders are working to create a healthy Africa by developing a technology system that medical practitioners and medical offices may utilize to solve issues in the provision of effective healthcare. The goal of mPharma is to connect patients, hospitals, and pharmacies in order for doctors, hospitals, and patients to be aware of the precise location and availability of medicines for improved access.
mPharma is constantly enhancing health interventions, bridging gaps in healthcare supply, and bringing important services closer to communities through online and offline channels by increasing patients’ access to pharmaceuticals at lower costs while maintaining quality.